Geffen Kleinstern
Geffen Kleinstern
Zuckerman Faculty Scholar Geffen Kleinstern publishes paper in Blood
University of Haifa
Paper abstract:
Newly diagnosed chronic lymphocytic leukemia (CLL) patients are monitored regularly for disease progression to delay the impact of treatments on the patients’ quality of life (QoL). However, studies have reported mixed results on the QoL between active surveillance patients compared to active treatment patients. Herein we performed a cross-sectional study to examine the impact of active surveillance and active treatment on health related QoL in CLL patients.
